One-Year Outcomes of Second-Generation Trabecular Micro-Bypass Stents (iStent Inject) Implantation with Cataract Surgery in Different Glaucoma Subtypes and Severities
One-Year Outcomes of Second-Generation Trabecular Micro-Bypass Stents (iStent Inject) Implantation with Cataract Surgery in Different Glaucoma Subtypes and Severities
复制标题
DOI：
10.1007/s40123-019-00214-z
复制
发表时间：
2019-12-01
影响因子：
3.3
通讯作者：
Harasymowycz, Paul
中科院分区：
文献类型：
--
作者：
Salimi, Ali;Lapointe, Julie;Harasymowycz, Paul
目的评价两种第二代小梁微旁路支架(iStent注射)联合白内障手术治疗不同类型和严重程度青光眼的1年疗效和安全性。方法来自加拿大学术眼科中心的单个外科医生的连续病例系列包括白内障、青光眼和需要降低眼压和/或药物的受试者。12个月的结果包括平均眼压、药物负担以及有眼压的眼睛所占比例
Purpose To assess the 1-year efficacy and safety of the implantation of two second-generation trabecular micro-bypass stents (iStent Inject) with concomitant cataract surgery in various subtypes and severities of glaucoma. Methods This single-surgeon, consecutive case series from a Canadian academic ophthalmology center included subjects with cataract, glaucoma, and the need to reduce intraocular pressure (IOP) and/or medications. The 12-month outcomes included mean IOP and medication burden as well as the proportions of eyes with IOP